• Home
• GJF
  • Joint Wound Care Formulary
  • . . . Introduction
  • 1. Gastro-Intestinal System
  • 2. Cardiovascular System
  • 3. Respiratory System
  • 4. Central Nervous System
  • 5. Infections
  • 6. Endocrine System
  • 7. Obstetrics, Gynaecology and Urinary Tract Disorders
  • 8. Malignant Disease and Immunosuppresion
  • 9. Nutrition and Blood
  • 10. Musculoskeletal and Joint Disease
  • 11. Eye
  • 12. Ear, Nose and Oropharynx
  • 13. Skin
  • 14. Immunological products and vaccines
  • 15. Anaesthesia
    • 15.1 General anaesthesia
      • 15.1.1 Intravenous Anaesthetics
      • 15.1.2 Inhalational Anaesthetics
      • 15.1.3 Antimuscarinic Drugs
      • 15.1.4 Sedative and Analgesic Peri-Operative Drugs
      • 15.1.5 Muscle Relaxants
      • 15.1.6 Drugs for reversal of neuromuscular blockade
      • 15.1.7 Antagonists for Central and Respiratory Depression
      • 15.1.8 Drugs for Malignant Hyperthermia
    • 15.2 Local anaesthesia
  • Appendix 1. Drugs for emergency use in General Practice
  • Appendix 2. Palliative Care
  • Appendix 3. Oral Nutritional Supplements (ONS)
  • Appendix 4. Gluten-free and cow's milk protein-free products
  • Medicines No Longer included in the GJF
  • Medicines not recommended for use in NHS Grampian
• eGJF
• Medicines Management
• Policies
• News Letters
• Shared Care Protocols
• Patient Group Directions

15.1.7 Antagonists for central and respiratory depression

The drugs in this section should only be administered by, or under direct supervision of personnel experienced in their use.

See under Respiratory System, see 3.5.

Previous: Drugs for reversal of neuromuscular blockade | Top | Next: Drugs for malignant hyperthermia